Remibrutinib shows promise in treating generalized myasthenia gravis, with ongoing trials assessing its efficacy and safety for patients.
Louie Pasculli
Advertisement
Articles by Louie Pasculli
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
FDA Clears First Alzheimer Blood Test for Adults as Young as 40
2
5 Things to Know About the 2026 ESC Heart Failure Guidelines
3
FDA Shortens Tarlatamab Monitoring, Widens Access to SCLC Care
4
MFN Drug Agreements Could Raise Prices Worldwide
5